Markets
BSE See NSE See 28,661.58
192.83 (0.68%)
collapse Related Readings collapse

US FDA’s Alert On Wockhardt: Much Ado About Nothing?

| 5/30/2013 9:02 PM Thursday

Pharma giant Wockhardt has received a strong setback after the US FDA sounded an alert on its Waluj manufacturing facility, after which the stock was hammered by more than 25 per cent in just two trading sessions. The market, however, seems to be overreacting to these developments. Shrikant Akolkar tells us more.

One of the worst things to happen to any stock is for it to get hit by factors which are apparently serious but on deeper exploration seem to be routine. This happens chiefly due to investors’ knee-jerk reaction to news flows which creates humongous negativity around it. One company which has recently been hit by this syndrome is Wockhardt.

We had recommended Wockhardt in DSIJ Vol. 28, Issue # 9 (dated 21 April, 2013) in our cover story ‘Cherry Picking’. The scrip was severely hammered following the recent US FDA alert on its manufacturing facility located in Waluj, Aurangabad district of Maharashtra. In just two trading sessions alone (May 23 and 24, 2013) it lost more than 25 per cent in value. Currently, the stock is down 35 per cent from where we had recommended it. Investors who have acted on our advice would surely be jittery in the wake of such a slide in the stock’s price. What should their future course in this counter be? Should one sell and book losses or wait out the depression? Here are the answers that you would be looking out for.

To start with, the hammering of the stock was a knee-jerk reaction arising out of fears fuelled by a particular event. This fear was accentuated by many other factors that were external to the company. The principal factor among these was the developments in Ranbaxy earlier in the same week.

Ranbaxy, the pharma company now owned by Daichhi Sankyo, pleaded guilty before the United States Department of Justice on compliance related issues in two of its manufacturing facilities. This was in any case weighing heavily on pharma stocks. The alert on Wockhardt’s Waluj facility came immediately after this, and dampened the sentiment on the stock.

What is worth noting is that Ranbaxy had ignored earlier malpractices, the consequences of which it had to bear. Wockhardt, however, had invited the US FDA team to audit its new injectables unit at Waluj. This is what differentiates between the two companies.

Find More Articles on: DSIJ Magazine, Special Report, Stock Recommendations, Fundamental Picks, Product, Large Cap

«« First « Previous |1 2 | Last ››

DSIJ
Mindshare

Markets may open flat to positive amidst subtle global cues and caution ahead of the high voltage domestic political stir

Markets may open flat to positive amidst subtle global cues and caution ahead of the high voltage domestic political stir

At 8:06 am, SGX Nifty index gained 16 points to 8,892, indicating a positive start for Indian equities.

Coal imports decline 22% in January

Coal imports decline 22% in January

Coal imports by India declined 22% in January 2017 to 14.31 million tonnes from 18.28 million tonnes in January last year. The drop in imports was mainly due to drop in demand from state distribution companies (discoms) as they were saddled with oversupplies.

TCS to buyback shares at 13.7% premium

TCS to buyback shares at 13.7% premium

Tata Consultancy Services (TCS) has approved buyback of up to 5.6 crore equity shares at a price of Rs 2850. The company’s aggregate amount for the buyback will not exceed Rs 16,000 crore. 

Overnight Digest- Stocks to look out for on February 21

Overnight Digest- Stocks to look out for on February 21

The stocks which could witness significant movement on February 21 are TVS Motor Company, Siemens, Intellect Design Arena, Rural Electrification Corporation, Castrol India/ ITD Cementation India.

Havells-Lloyd deal: what should a retail investor do now

Havells-Lloyd deal: what should a retail investor do now

In a significant development on the very first day of the week, Lloyd Electric & Engineering sold its consumer durable business to Havells India at Rs 1550 crore.

Markets start the week on a positive note

Markets start the week on a positive note

Indian markets started the week on a positive note. Both stock exchanges were able to surge more than half a per cent in Monday’s trading session.

Jindal Steel & Power touches 52-week high

Jindal Steel & Power touches 52-week high

The positive news of asset optimisation enthused traders and investors and the company's stock gained as much as 9.95 per cent and touched 52-week high in intra-day trade to Rs 102.20 on the Bombay Stock Exchange.

Ten stocks close to their 52-week low

 Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 1.01 p.m. on February 20.

Dilip Buildcon Bags Tuljapur-Ausa Four-laning project worth Rs 911 Cr.

 Dilip Buildcon Bags Tuljapur-Ausa Four-laning project worth Rs 911 Cr.

The company’s share is currently trading at Rs. 293.1, up by 19.35 points or 7.07 per cent from the previous close of Rs 273.75.

Marksans Pharma hits upper circuit

Marksans Pharma hits upper circuit

Marksans Pharma has been steadily trading in green on Monday's trading session owing to successful completion of its manufacturing plant inspection.

Market
CHIT CHAT

What is your view on markets today?

200  Characters Remaining.
Please LOGIN  to post your comments or Click here to go back.
Harsh Boricha Feb 20 07:41PM
tata products guys
shubham soni Feb 20 03:37PM
It which sector bro
Manish Tyagi Feb 20 03:34PM
tcs
DEVENDRA SINGH Feb 20 03:31PM
IT sector boom boom
shubham soni Feb 20 03:05PM
Kalyan steel

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »